[1]平兰芝,黄小楼,胡天俊,等.CaMKⅡ在心血管疾病中的研究[J].医学信息,2022,35(10):59-61,77.[doi:10.3969/j.issn.1006-1959.2022.10.014]
 PING Lan-zhi,HUANG Xiao-lou,HU Tian-jun,et al.Research on the Role of CaMKⅡ in Cardiovascular Diseases[J].Medical Information,2022,35(10):59-61,77.[doi:10.3969/j.issn.1006-1959.2022.10.014]
点击复制

CaMKⅡ在心血管疾病中的研究()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年10期
页码:
59-61,77
栏目:
综述
出版日期:
2022-05-15

文章信息/Info

Title:
Research on the Role of CaMKⅡ in Cardiovascular Diseases
文章编号:
1006-1959(2022)10-0059-04
作者:
平兰芝黄小楼胡天俊
(1.贵州中医药大学针灸推拿学院,贵州 贵阳 550025;2.贵州中医药大学第一附属医院针灸科,贵州 贵阳 550025;3.盘州市中医院康复科,贵州 盘州 553500)
Author(s):
PING Lan-zhiHUANG Xiao-louHU Tian-junet al.
(1.Acupuncture and Tuina College,Guizhou University of Traditional Chinese Medicine,Guiyang 550025,Guizhou,China;2.Department of Acupuncture and Moxibustion,the First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine,Guiyang 55002
关键词:
钙/钙调蛋白依赖性蛋白激酶Ⅱ心血管疾病心律失常心力衰竭
Keywords:
Calcium/calmodulin-dependent protein kinase ⅡCardiovascular diseasesArrhythmiaHeart failure
分类号:
R54
DOI:
10.3969/j.issn.1006-1959.2022.10.014
文献标志码:
A
摘要:
钙/钙调蛋白依赖性蛋白激酶Ⅱ(CaMKⅡ)是心肌细胞内钙离子信号变化的重要感受器,在心血管疾病中广泛表达。当细胞内Ca2+水平升高时,Ca2+与钙调蛋白(CaM)结合并活化CaMKⅡ,从而激活多条相关信号通路影响心血管疾病的发生发展,其中包括触发炎症引起心脏重塑不良、介导心肌细胞凋亡诱导心衰发生等。本文就CaMKⅡ分子结构、亚型、活性及其在心血管疾病相关通路激活中的作用作一综述,旨在临床治疗提供参考。
Abstract:
Calcium/calmodulin-dependent protein kinase Ⅱ (CaMKⅡ) is an important sensor of calcium signal changes in myocardial cells and widely expressed in cardiovascular diseases. When the intracellular Ca2+ level increases, Ca2+ binds to calmodulin (CaM) and activates CaMKⅡ, thereby activating multiple related signaling pathways that affect the occurrence and development of cardiovascular disease, including triggering inflammation to cause poor cardiac remodeling and mediating cardiomyocyte apoptosis to induce heart failure. In this paper, the molecular structure, subtype, activity of CaMKⅡ and its role in the activation of cardiovascular disease-related pathways are reviewed to provide reference for clinical treatment.

参考文献/References:

[1]中国心血管健康与疾病报告编写组.中国心血管健康与疾病报告2019概要[J].中国循环杂志,2020,35(9):833-854.[2]Ling H,Gray CB,Zambon AC,et al.Ca2+/Calmodulin-dependent protein kinase Ⅱδmediates myocardial ischemia/reperfusion injury through nuclear factor-κB[J].Circ Res,2013,12(6):935-944.[3]Zhao L,Cheng G,Jin R,et al.Deletion of Interleukin-6 Attenuates Pressure Overload-Induced Left Ventricular Hypertrophy and Dysfunction[J].Circ Res,2016,118(12):1918-1929.[4]Yan J,Thomson JK,Zhao W,et al.Role of Stress Kinase JNK in Binge Alcohol-Evoked Atrial Arrhythmia.[J]Am Coll Cardiol,2018,71(13):1459-1470.[5]Grimm M,Ling H,Brown JH.Crossing signals:relationships between β-adrenergic stimulation and CaMKⅡ activation[J].Heart Rhythm,2011,8(8):1296-1298.[6]李胜胜,骞爱荣,罗明志,等.钙调蛋白激酶Ⅱ对细胞生理功能的调节作用[J].生命的化学,2011,31(1):95-101.[7]Bayer KU,Schulman H.Regulation of signal transduction by protein targeting: the case for CaMKII[J].Biochem Biophys Res Commun,2001,289(5):917-923.[8]Gray CB,Heller Brown J.CaMKⅡdelta subtypes:localization and function[J].Front Pharmacol,2014(5):15. [9]Srinivasan M,Edman CF,Schulman H.Alternative splicing introduces a nuclear localization signal that targets multifunctional CaM kinase to the nucleus[J].Cell Biol,1994,126(4):839-852.[10]贺文彬,张俊龙,于龙川,等.钙调素依赖性蛋白激酶Ⅱ的分子调节与突触可塑性[J].中国药理学通报,2014,30(7):897-901.[11]Zalcman G,Federman N,Romano A.CaMKⅡ Isoforms in Learning and Memory: Localization and Function[J].Front Mol Neurosci,2018(11):445.[12]Erickson JR.Mechanisms of CaMKⅡ Activation in the Heart[J].Front Pharmacol,2014(5):59.[13]Rosenberg OS,Deindl S,Sung RJ,et al.Structure of the autoinhibited kinase domain of CaMKⅡ and SAXS analysis of the holoenzyme[J].Cell,2005,123(5):849-860.[14]Rellos P,Pike AC,Niesen FH,et al.Structure of the CaMKⅡdelta/calmodulin complex reveals the molecular mechanism of CaMKⅡ kinase activation[J].PLoS Biol,2010,8(7):e1000426.[15]Erickson JR,He BJ,Grumbach IM,et al.CaMKⅡ in the cardiovascular system:sensing redox states[J].Physiol Rev,2011,91(3):889-915.[16]Erickson JR,Pereira L,Wang L,et al.Diabetic hyperglycaemia activates CaMKⅡ and arrhythmias by O-linked glycosylation[J].Nature,2013,502(7471):372-376.[17]Gutierrez DA,Fernandez-Tenorio M,Ogrodnik J,et al.NO-dependent CaMKⅡ activation during β-adrenergic stimulation of cardiac muscle[J].Cardiovasc Res,2013,100(3):392-401.[18]Jalan-Sakrikar N,Bartlett RK,Baucum AJ 2nd,et al.Substrate-selective and calcium-independent activation of CaMKⅡ by α-actinin[J].Biol Chem,2012,287(19):15275-15283.[19]Cheng H,Lederer WJ.Calcium sparks[J].Physiol Rev,2008,88(4):1491-1545.[20]Gordon JW,Shaw JA,Kirshenbaum LA.Multiple facets of NF-κB in the heart:to be or not to NF-κB[J].Circ Res,2011,108(9):1122-1132.[21]Martin TP,McCluskey C,Cunningham MR,et al.CaMKIIδ interacts directly with IKKβ and modulates NF-κB signalling in adult cardiac fibroblasts[J].Cell Signal,2018,51:166-175.[22]Gray CB,Suetomi T,Xiang S,et al.CaMKIIδ subtypes differentially regulate infarct formation following ex vivo myocardial ischemia/reperfusion through NF-κB and TNF-α[J].J Mol Cell Cardiol,2017,103:48-55. [23]Suetomi T,Willeford A,Brand CS,et al.Inflammation and NLRP3 Inflammasome Activation Initiated in Response to Pressure Overload by Ca2+/Calmodulin-Dependent Protein Kinase Ⅱ δ Signaling in Cardiomyocytes Are Essential for Adverse Cardiac Remodeling[J].Circulation,2018,138(22):2530-2544.[24]Willeford A,Suetomi T,Nickle A,et al.CaMKⅡδ-mediated inflammatory gene expression and inflammasome activation in cardiomyocytes initiate inflammation and induce fibrosis[J].JCI Insight,2018,3(12):e97054.[25]Kunisada K,Negoro S,Tone E,et al.Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy[J].Proc Natl Acad Sci U S A,2000,97(1):315-319. [26]Hulsurkar M,Quick AP,Wehrens XH.STAT3: a link between CaMKⅡ-βIV-spectrin and maladaptive remodeling?[J].Clin Invest,2018,128(12):5219-5221. [27]Cai K,Chen H.MiR-625-5p Inhibits Cardiac Hypertrophy Through Targeting STAT3 and CaMKⅡ[J].Hum Gene Ther Clin Dev,2019,30(4):182-191. [28]Chang L,Karin M.Mammalian MAP kinase signalling cascades[J].Nature,2001,410(6824):37-40. [29]Yokota T,Wang Y.p38 MAP kinases in the heart[J].Gene,2016,575(2Pt2):369-376. [30]Palomeque J,Rueda OV,Sapia L,et al.Angiotensin Ⅱ-induced oxidative stress resets the Ca2+ dependence of Ca2+-calmodulin protein kinase Ⅱ and promotes a death pathway conserved across different species[J].Circ Res,2009,105(12):1204-1212. [31]周昌清,倪黎,晏小妮,等.美托洛尔下调CaMKⅡδC-p38通路对异丙肾上腺素诱导心力衰竭的保护机制[J].中国分子心脏病学杂志,2008(5):255-263.[32]Voskoboinik A,Prabhu S,Ling LH,et al.Alcohol and Atrial Fibrillation:A Sobering Review[J].J Am Coll Cardiol,2016,68(23):2567-2576. [33]Wang X,Lu Y,Xie B,et al.Chronic ethanol feeding potentiates Fas Jo2-induced hepatotoxicity: role of CYP2E1 and TNF-alpha and activation of JNK and P38 MAP kinase[J].Free Radic Biol Med,2009,47(5):518-528.[34]Huang Y,Li L,Li X,et al.Ginseng Compatibility Environment Attenuates Toxicity and Keeps Efficacy in Cor Pulmonale Treated by Fuzi Beimu Incompatibility Through the Coordinated Crosstalk of PKA and Epac Signaling Pathways[J].Front Pharmacol,2018,9:634. [35]Zhang X,Szeto C,Gao E,et al.Cardiotoxic and cardioprotective features of chronic β-adrenergic signaling[J].Circ Res,2013,112(3):498-509.[36]孙凤姣,张译丹,张密霞,等.β-AR/PKA/CaMK Ⅱ信号通路在阿霉素诱导大鼠心肌细胞凋亡中的作用[J].中国药理学通报,2017,33(3):360-365.[37]王赛,胡烨,包斯图.黄芩苷对扩张型心肌病大鼠心室重构、心室肌细胞凋亡及β1-AR/PKA/CaMKⅡ信号通路的影响[J].中国实验方剂学杂志,2018,24(9):140-144.

相似文献/References:

[1]郭俊林,张 立.基质金属蛋白酶-2与冠状动脉粥样硬化性疾病的研究进展[J].医学信息,2018,31(04):27.[doi:10.3969/j.issn.1006-1959.2018.04.010]
 GUO Jun-lin,ZHANG Li.Progress of the Researchon Matrix Metalloproteinase-2 and Coronary Atherosclerotic Disease[J].Medical Information,2018,31(10):27.[doi:10.3969/j.issn.1006-1959.2018.04.010]
[2]张 慧,黄艳群,王 妮,等.基于美国全国住院病人样本的心血管疾病研究进展[J].医学信息,2018,31(07):43.[doi:10.3969/j.issn.1006-1959.2018.06.015]
 ZHANG Hui,HUANG Yan-qun,WANG Ni,et al.Research Progress of Cardiovascular Disease Based on National Inpatient Sample[J].Medical Information,2018,31(10):43.[doi:10.3969/j.issn.1006-1959.2018.06.015]
[3]李 晶,黄 波.抗血小板药物治疗心血管疾病的研究现状[J].医学信息,2022,35(10):83.[doi:10.3969/j.issn.1006-1959.2022.10.020]
 LI Jing,HUANG Bo.Research Status of Antiplatelet Drugs in the Treatment of Cardiovascular Diseases[J].Medical Information,2022,35(10):83.[doi:10.3969/j.issn.1006-1959.2022.10.020]
[4]汤海霞,班 涛.大黄素与心血管疾病的研究[J].医学信息,2022,35(11):19.[doi:10.3969/j.issn.1006-1959.2022.11.006]
 TANG Hai-xia,BAN Tao.Research on Emodin and Cardiovascular Diseases[J].Medical Information,2022,35(10):19.[doi:10.3969/j.issn.1006-1959.2022.11.006]
[5]徐炜棉,郭金莲,王燕琴,等.铁代谢及铁蛋白与心血管疾病关系的现状分析[J].医学信息,2018,31(22):39.[doi:10.3969/j.issn.1006-1959.2018.22.012]
 XU Wei-mian,GUO Jin-lian,WANG Yan-qin,et al.Analysis of the Relationship between Iron Metabolism and Ferritin and Cardiovascular Diseases[J].Medical Information,2018,31(10):39.[doi:10.3969/j.issn.1006-1959.2018.22.012]
[6]刘瑞芳,赵 华,史红娟,等.益生菌与2型糖尿病心血管疾病的研究进展[J].医学信息,2019,32(18):29.[doi:10.3969/j.issn.1006-1959.2019.18.010]
 LIU Rui-fang,ZHAO Hua,SHI Hong-juan,et al.Advances in Research on Probiotics and Cardiovascular Diseases in Type 2 Diabetes[J].Medical Information,2019,32(10):29.[doi:10.3969/j.issn.1006-1959.2019.18.010]
[7]闫娜娜,李雪萍,李 亚,等.FGF23与心血管疾病的研究进展[J].医学信息,2019,32(19):43.[doi:10.3969/j.issn.1006-1959.2019.19.014]
 YAN Na-na,LI Xue-ping,LI Ya,et al.Progress in Research on FGF23 and Cardiovascular Diseases[J].Medical Information,2019,32(10):43.[doi:10.3969/j.issn.1006-1959.2019.19.014]
[8]袁国铭,陈新利,袁国娜,等.心脏病健康知识系统构建与应用[J].医学信息,2019,32(22):8.[doi:10.3969/j.issn.1006-1959.2019.22.003]
 YUAN Guo-ming,CHEN Xin-li,YUAN Guo-na,et al.The Construction and Application of Heart Health Knowledge System[J].Medical Information,2019,32(10):8.[doi:10.3969/j.issn.1006-1959.2019.22.003]
[9]杨 敏,汤云昭,倪长林.2型糖尿病患者心血管疾病的发病机制[J].医学信息,2020,33(06):56.[doi:10.3969/j.issn.1006-1959.2020.06.017]
 YANG Min,TANG Yun-zhao,NI Chang-lin.The Pathogenesis of Cardiovascular Disease in Patients with Type 2 Diabetes[J].Medical Information,2020,33(10):56.[doi:10.3969/j.issn.1006-1959.2020.06.017]
[10]左 楠,刘文辉,李 伟,等.牙周炎与心血管疾病联系机制的研究[J].医学信息,2021,34(10):50.[doi:10.3969/j.issn.1006-1959.2021.10.014]
 ZUO Nan,LIU Wen-hui,LI Wei,et al.Study on the Link Mechanism Between Periodontitis and Cardiovascular Disease[J].Medical Information,2021,34(10):50.[doi:10.3969/j.issn.1006-1959.2021.10.014]

更新日期/Last Update: 1900-01-01